Innovation In OTC Switches Takes Multimedia Approach In US FDA Draft Guidance
Executive Summary
Sponsors can point consumers to video displays, website information and mobile apps to help them choose products that have been switched from Rx to OTC. Draft guidance on innovative switch applications to be followed by rule-making in near future.
You may also be interested in...
A New OTC Switch Pathway In US At Last: Acronym Isn’t The Only Thing That’s Changed
FDA proposes a novel pathway to permit OTC drugs to be marketed with additional controls to assure appropriate use, more than a decade after floating the idea. The pathway has a new name (“ACNU” not “NSURE”) and very different commercial dynamics.
A New OTC Pathway At Last: The Acronym Isn’t The Only Thing That’s Changed
The US FDA is proposing a novel pathway to permit OTC drugs to be marketed with some additional controls to assure appropriate use, more than a decade after floating the idea. The pathway has a new name (“ACNU” not “NSURE”) and very different commercial dynamics.
Thinking About Switching? Dr Gauld On The Go-To Markets Today
In this first installment of an exclusive three-part series, global switch expert Dr Natalie Gauld speaks to HBW Insight about what makes a country an attractive environment for switching and highlights those markets leading the way today.